March 4, 2024

Diagnostic Testing Market Size to Worth Around US$ 348.75 Billion by 2030

[150+ Pages Report] As per the latest Research and survey report issued by Precedence Research, the global diagnostic testing market was valued at around USD 165.58 billion in 2021 and is expected to register revenues worth USD 348.75 billion by the end of 2030, growing at an exceptional CAGR of approximately 8.63% between 2022 and 2030.

Diagnostic Testing Market

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1984

Diagnostic Testing Market Report Scope

A recent study by Precedence Research on the diagnostic testing market offers a forecast for 2022 and 2030. The study analyzes crucial trends that are currently determining the growth of the diagnostic testing market. This report explicates on vital dynamics such as the drivers, restraints, and opportunities for key market players, along with key stakeholders as well as emerging players associated with the manufacturing of diagnostic testing. The study also provides the dynamics that are responsible for influencing the future status of the diagnostic testing market over the forecast period.

A detailed assessment of the diagnostic testing market value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the diagnostic testing market along with their product portfolio enhances the reliability of this comprehensive research study.

Competition Landscape

The report has engulfed a chapter on the global diagnostic testing market’s competitive landscape, which provides detailed analysis and insights on companies offering diagnostic testing. Profiles of key companies, along with a strategic overview of their M&A and expansion plans across geographies, have been delivered in this chapter. This chapter is priceless for report readers, as its enables them in gauging their growth potential in the market and implement key strategies for extending their market reach.

This chapter offers key recommendations for both new and existing market participants, enabling them to emerge sustainably and profitably. Intelligence on the market players has been delivered on the basis of their product overview, SWOT analysis, key developments, key financials and company overview. Occupancy of these market participants has been tracked by the report and portrayed via an intensity map.

Read Also@ Artificial Intelligence in Transportation Market Size to Worth Around US$ 14.79 Billion by 2030

Some of the Prominent Players in the Diagnostic Testing Market Include:
  • F-Hoffman La-Rcohe Ltd. (Switzerland)
  • Danaher (US)
  • BD (US)
  • Thermo Fisher Scientific Inc. (US)
  • ACON Laboratories Inc. (US)
  • Hemosure, Inc. (US)
  • MicroGen Diagnostics (US)
  • Grifols, S.A (Spain)
  • BODITECH MED INC. (South Korea)
  • Chembio Diagnostic Systems, Inc. (US)
  • Nanoentek (South Korea)
  • DiaSorin S.p.A. (Italy)
  • Bio-Rad Laboratories, Inc. (US)
  • BIOMEDOMICS INC (US)
  • EKF Diagnostics Holdings plc (UK)
  • Siemens Healthcare GmbH (Germany)
  • PerkinElmer Inc. (US)
  • bioMérieux SA (France)
  • ARKRAY USA, Inc. (US)
  • Biohit Oyj (Finland)
  • Quidel Corporation (US)
  • Illumina, Inc. (US)
  • Lamdagen Corporation (US)
  • LifeSign LLC. (US)
  • Medixbiochemica (Finaland)
  • Nova Biomedical (US)
  • Ortho Clinical Diagnostics (US)
  • Sannuo Biosensing Co., Ltd. (US)
  • STRECK (US)
  • Sysmex Corporation (Japan)
Diagnostic Testing Market Segmentation

By Type

  • Clinical Diagnostic
  • Home Diagnostic

By Application

  • Cardiology
  • Oncology
  • Neurology
  • Orthopedics
  • Gastroenterology
  • Gynecology
  • Odontology
  • Others

By Approach

  • Molecular Diagnostic Instrument
  • In-Vitro Diagnostic Instrument
  • Point Of Care Testing Instrument

By Solution

  • Services
  • Products

By Technology

By Mode of Testing

  • Prescription Based Testing
  • OTC Testing

By Sample Type

  • Urine
  • Saliva
  • Blood
  • Hair
  • Sweat
  • Others

By Testing Type

  • Biochemistry
  • Hematology
  • Microbiology
  • Histopathology
  • Others

By Age

  • Pediatric
  • Adult & Geriatric

By Distribution Channel

  • Direct Tenders
  • Retail Sales
  • Online Sales

By End User

  • Hospitals, Diagnostic Center
  • Research Labs and Institutes
  • Research Institute
  • Homecare
  • Blood Banks
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

Regional Segmentation

  • Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
  • Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
  • North America [United States, Canada, Mexico]
  • South America [Brazil, Argentina, Columbia, Chile, Peru]
  • Middle East & Africa [GCC, North Africa, South Africa]

Regional Analysis

The research report includes a detailed study of regions of North America, Europe, China, Japan and Rest of the World. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.

The report provides in-depth segment analysis of the global diagnostic testing market, thereby providing valuable insights at macro as well as micro levels. Analysis of major countries, which hold growth opportunities or account for significant share has also been included as part of geographic analysis of the diagnostic testing market.

The report includes country-wise and region-wise market size for the period 2022-2030. It also includes market size and forecast by segments in terms of production capacity, price and revenue for the period 2022-2030.

Why should you invest in this report?

If you are aiming to enter the global diagnostic testing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for diagnostic testing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Ages

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Eleven Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Diagnostic Testing Market, By Type

7.1. Diagnostic Testing Market, by Type, 2022-2030

7.1.1. Clinical Diagnostic

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Home Diagnostic

7.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Diagnostic Testing Market, By Application

8.1. Diagnostic Testing Market, by Application, 2022-2030

8.1.1. Cardiology

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Oncology

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Neurology

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Orthopedics

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Gastroenterology

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Gynecology

8.1.6.1. Market Revenue and Forecast (2017-2030)

8.1.7. Odontology

8.1.8.1. Market Revenue and Forecast (2017-2030)

8.1.9. Others

8.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Diagnostic Testing Market, By Approach

9.1. Diagnostic Testing Market, by Approach, 2022-2030

9.1.1. Molecular Diagnostic Instrument

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. In-Vitro Diagnostic Instrument

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Point Of Care Testing Instrument

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Diagnostic Testing Market, By Solution

10.1. Diagnostic Testing Market, by Solution, 2022-2030

10.1.1. Services

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Products

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Diagnostic Testing Market, By Technology

11.1. Diagnostic Testing Market, by Technology, 2022-2030

11.1.1. Immunoassay-Based

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. PCR-Based

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Next-generation Sequencing

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Spectroscopy-Based

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Chromatography-Based

11.1.5.1. Market Revenue and Forecast (2017-2030)

11.1.6. Microfluidics

11.1.6.1. Market Revenue and Forecast (2017-2030)

11.1.7. Substrate Technology

11.1.7.1. Market Revenue and Forecast (2017-2030)

11.1.8. Others

11.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Diagnostic Testing Market, By Mode of Testing

12.1. Diagnostic Testing Market, by Mode of Testing, 2022-2030

12.1.1. Prescription Based Testing

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. OTC Testing

12.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Diagnostic Testing Market, By Sample Type

13.1. Diagnostic Testing Market, by Sample Type, 2022-2030

13.1.1. Urine

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Saliva

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Blood

13.1.3.1. Market Revenue and Forecast (2017-2030)

13.1.4. Hair

13.1.4.1. Market Revenue and Forecast (2017-2030)

13.1.5. Sweat

13.1.5.1. Market Revenue and Forecast (2017-2030)

13.1.6. Others

13.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Diagnostic Testing Market, By Testing Type

14.1. Diagnostic Testing Market, by Testing Type, 2022-2030

14.1.1. Biochemistry

14.1.1.1. Market Revenue and Forecast (2017-2030)

14.1.2. Hematology

14.1.2.1. Market Revenue and Forecast (2017-2030)

14.1.3. Microbiology

14.1.3.1. Market Revenue and Forecast (2017-2030)

14.1.4. Histopathology

14.1.4.1. Market Revenue and Forecast (2017-2030)

14.1.5. Others

14.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 15. Global Diagnostic Testing Market, By Age

15.1. Diagnostic Testing Market, by Age, 2022-2030

15.1.1. Pediatric

15.1.1.1. Market Revenue and Forecast (2017-2030)

15.1.2. Adult & Geriatric

15.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 16. Global Diagnostic Testing Market, By Distribution Channel

16.1. Diagnostic Testing Market, by Distribution Channel, 2022-2030

16.1.1. Direct Tenders

16.1.1.1. Market Revenue and Forecast (2017-2030)

16.1.2. Retail Sales

16.1.2.1. Market Revenue and Forecast (2017-2030)

16.1.3. Online Sales

16.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 17. Global Diagnostic Testing Market, By End User

17.1. Diagnostic Testing Market, by End User, 2022-2030

17.1.1. Hospitals, Diagnostic Center

17.1.1.1. Market Revenue and Forecast (2017-2030)

17.1.2. Research Labs and Institutes

17.1.2.1. Market Revenue and Forecast (2017-2030)

17.1.3. Research Institute

17.1.3.1. Market Revenue and Forecast (2017-2030)

17.1.4. Homecare

17.1.4.1. Market Revenue and Forecast (2017-2030)

17.1.5. Blood Banks

17.1.5.1. Market Revenue and Forecast (2017-2030)

17.1.6. Specialty Clinics

17.1.6.1. Market Revenue and Forecast (2017-2030)

17.1.7. Ambulatory Surgical Centers

17.1.7.1. Market Revenue and Forecast (2017-2030)

17.1.8. Others

17.1.8.1. Market Revenue and Forecast (2017-2030)

 

Chapter 18. Global Diagnostic Testing Market, Regional Estimates and Trend Forecast

18.1. North America

18.1.1. Market Revenue and Forecast, by Type (2017-2030)

18.1.2. Market Revenue and Forecast, by Application (2017-2030)

18.1.3. Market Revenue and Forecast, by Approach (2017-2030)

18.1.4. Market Revenue and Forecast, by Solution (2017-2030)

18.1.5. Market Revenue and Forecast, by Technology (2017-2030)

18.1.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.1.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.1.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.1.9. Market Revenue and Forecast, by Age (2017-2030)

18.1.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.1.11. Market Revenue and Forecast, by End User (2017-2030)

18.1.12. U.S.

18.1.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.1.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.1.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.1.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.1.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.1.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.1.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.1.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.1.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.1.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.1.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.1.12.12. Market Revenue and Forecast, by December (2017-2030)

18.1.12.13. Market Revenue and Forecast, by Eleven (2017-2030)

18.1.13. Rest of North America

18.1.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.1.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.1.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.1.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.1.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.1.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.1.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.1.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.1.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.1.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.1.13.11. Market Revenue and Forecast, by End User (2017-2030)

18.2. Europe

18.2.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.11. Market Revenue and Forecast, by End User (2017-2030)

18.2.12. UK

18.2.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.2.13. Germany

18.2.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.13.11. Market Revenue and Forecast, by End User (2017-2030)

18.2.14. France

18.2.14.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.14.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.14.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.14.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.14.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.14.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.14.11. Market Revenue and Forecast, by End User (2017-2030)

18.2.15. Rest of Europe

18.2.15.1. Market Revenue and Forecast, by Type (2017-2030)

18.2.15.2. Market Revenue and Forecast, by Application (2017-2030)

18.2.15.3. Market Revenue and Forecast, by Approach (2017-2030)

18.2.15.4. Market Revenue and Forecast, by Solution (2017-2030)

18.2.15.5. Market Revenue and Forecast, by Technology (2017-2030)

18.2.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.2.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.2.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.2.15.9. Market Revenue and Forecast, by Age (2017-2030)

18.2.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.2.15.11. Market Revenue and Forecast, by End User (2017-2030)

18.3. APAC

18.3.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.11. Market Revenue and Forecast, by End User (2017-2030)

18.3.12. India

18.3.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.3.13. China

18.3.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.13.11. Market Revenue and Forecast, by End User (2017-2030)

18.3.14. Japan

18.3.14.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.14.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.14.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.14.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.14.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.14.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.14.11. Market Revenue and Forecast, by End User (2017-2030)

18.3.15. Rest of APAC

18.3.15.1. Market Revenue and Forecast, by Type (2017-2030)

18.3.15.2. Market Revenue and Forecast, by Application (2017-2030)

18.3.15.3. Market Revenue and Forecast, by Approach (2017-2030)

18.3.15.4. Market Revenue and Forecast, by Solution (2017-2030)

18.3.15.5. Market Revenue and Forecast, by Technology (2017-2030)

18.3.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.3.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.3.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.3.15.9. Market Revenue and Forecast, by Age (2017-2030)

18.3.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.3.15.11. Market Revenue and Forecast, by End User (2017-2030)

18.4. MEA

18.4.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.11. Market Revenue and Forecast, by End User (2017-2030)

18.4.12. GCC

18.4.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.4.13. North Africa

18.4.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.13.11. Market Revenue and Forecast, by End User (2017-2030)

18.4.14. South Africa

18.4.14.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.14.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.14.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.14.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.14.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.14.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.14.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.14.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.14.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.14.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.14.11. Market Revenue and Forecast, by End User (2017-2030)

18.4.15. Rest of MEA

18.4.15.1. Market Revenue and Forecast, by Type (2017-2030)

18.4.15.2. Market Revenue and Forecast, by Application (2017-2030)

18.4.15.3. Market Revenue and Forecast, by Approach (2017-2030)

18.4.15.4. Market Revenue and Forecast, by Solution (2017-2030)

18.4.15.5. Market Revenue and Forecast, by Technology (2017-2030)

18.4.15.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.4.15.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.4.15.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.4.15.9. Market Revenue and Forecast, by Age (2017-2030)

18.4.15.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.4.15.11. Market Revenue and Forecast, by End User (2017-2030)

18.5. Latin America

18.5.1. Market Revenue and Forecast, by Type (2017-2030)

18.5.2. Market Revenue and Forecast, by Application (2017-2030)

18.5.3. Market Revenue and Forecast, by Approach (2017-2030)

18.5.4. Market Revenue and Forecast, by Solution (2017-2030)

18.5.5. Market Revenue and Forecast, by Technology (2017-2030)

18.5.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.5.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.5.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.5.9. Market Revenue and Forecast, by Age (2017-2030)

18.5.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.5.11. Market Revenue and Forecast, by End User (2017-2030)

18.5.12. Brazil

18.5.12.1. Market Revenue and Forecast, by Type (2017-2030)

18.5.12.2. Market Revenue and Forecast, by Application (2017-2030)

18.5.12.3. Market Revenue and Forecast, by Approach (2017-2030)

18.5.12.4. Market Revenue and Forecast, by Solution (2017-2030)

18.5.12.5. Market Revenue and Forecast, by Technology (2017-2030)

18.5.12.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.5.12.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.5.12.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.5.12.9. Market Revenue and Forecast, by Age (2017-2030)

18.5.12.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.5.12.11. Market Revenue and Forecast, by End User (2017-2030)

18.5.13. Rest of LATAM

18.5.13.1. Market Revenue and Forecast, by Type (2017-2030)

18.5.13.2. Market Revenue and Forecast, by Application (2017-2030)

18.5.13.3. Market Revenue and Forecast, by Approach (2017-2030)

18.5.13.4. Market Revenue and Forecast, by Solution (2017-2030)

18.5.13.5. Market Revenue and Forecast, by Technology (2017-2030)

18.5.13.6. Market Revenue and Forecast, by Sample Type (2017-2030)

18.5.13.7. Market Revenue and Forecast, by Mode of Testing (2017-2030)

18.5.13.8. Market Revenue and Forecast, by Testing Type (2017-2030)

18.5.13.9. Market Revenue and Forecast, by Age (2017-2030)

18.5.13.10. Market Revenue and Forecast, by Distribution Channel (2017-2030)

18.5.13.11. Market Revenue and Forecast, by End User (2017-2030)

Chapter 19. Company Profiles

19.1. F-Hoffman La-Rcohe Ltd. (Switzerland)

19.1.1. Company Overview

19.1.2. Product Offerings

19.1.3. Financial Performance

19.1.4. Recent Initiatives

19.2. Danaher (US)

19.2.1. Company Overview

19.2.2. Product Offerings

19.2.3. Financial Performance

19.2.4. Recent Initiatives

19.3. BD (US)

19.3.1. Company Overview

19.3.2. Product Offerings

19.3.3. Financial Performance

19.3.4. Recent Initiatives

19.4. Thermo Fisher Scientific Inc. (US)

19.4.1. Company Overview

19.4.2. Product Offerings

19.4.3. Financial Performance

19.4.4. Recent Initiatives

19.5. ACON Laboratories Inc. (US)

19.5.1. Company Overview

19.5.2. Product Offerings

19.5.3. Financial Performance

19.5.4. Recent Initiatives

19.6. Hemosure, Inc. (US)

19.6.1. Company Overview

19.6.2. Product Offerings

19.6.3. Financial Performance

19.6.4. Recent Initiatives

19.7. MicroGen Diagnostics (US)

19.7.1. Company Overview

19.7.2. Product Offerings

19.7.3. Financial Performance

19.7.4. Recent Initiatives

19.8. Grifols, S.A (Spain)

19.8.1. Company Overview

19.8.2. Product Offerings

19.8.3. Financial Performance

19.8.4. Recent Initiatives

19.9. BODITECH MED INC. (South Korea)

19.9.1. Company Overview

19.9.2. Product Offerings

19.9.3. Financial Performance

19.9.4. Recent Initiatives

19.10. Chembio Diagnostic Systems, Inc. (US)

19.10.1. Company Overview

19.10.2. Product Offerings

19.10.3. Financial Performance

19.10.4. Recent Initiatives

Chapter 20. Research Methodology

20.1. Primary Research

20.2. Secondary Research

20.3. Assumptions

Chapter 21. Appendix

21.1. About Us

21.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1984

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

Janet Edward

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Janet Edward →